[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Shalaev
S V
SV
D001241:Aspirin / Q000627:therapeutic use*; D002170:Canada; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D003328:Coronary Thrombosis / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D004176:Dipyridamole / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011446:Prospective Studies; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D014481:United States
D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone
Antiagreganty v profilaktike infarkta miokarda: rezu'ltaty prospektivnykh issledovaniĭ.